RxDoctor Payments Data

Mrinalini Meesala, MD

Cardiovascular Disease · Lancaster, PANPI 1972826816

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,054 of the $1,442 with a category attached, or 73.1%. Abbott accounts for 85.4% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $1,231, more than ten times the $114 reported in 2019. That places this record below the midpoint for cardiovascular disease clinicians in PA, where the typical reported total is $1,447.

$1,442in general payments, 2019–2025

Across 13 payments — averaging $110.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • Medtronic$100
  • Johnson & Johnson$59
  • Edwards Lifesciences$27
  • Abiomed$26

What the payments were for

  • Travel & lodging$1,05473%
  • Food & beverage$38827%

General payments by program year

19
20
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott7$1,231
Medtronic1$100
Johnson & Johnson2$59
Edwards Lifesciences1$27
Abiomed2$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,442 in reported general payments places this provider in the 45th percentile of 1,250 cardiovascular disease providers in Pennsylvania.

See all cardiovascular disease providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$147,204
Medicare patients
1,370
Services billed
2,501

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban68$93,848
Metoprolol Succinate130$2,169
Isosorbide Mononitrate ErIsosorbide Mononitrate44$845
Rosuvastatin Calcium65$518
Amlodipine Besylate107$518
Nitroglycerin45$344
Atorvastatin Calcium53$276
ClopidogrelClopidogrel Bisulfate23$256
Lisinopril71$221
Metoprolol Tartrate69$216
Warfarin Sodium14$192
Amiodarone Hcl16$183
Carvedilol22$183
Potassium Chloride18$174
Furosemide40$168

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Lancaster

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →